First AstraZeneca, then Sanofi-GSK, Johnson & Johnson, Pfizer-BioNTech and finally CureVac: since August, the European Commission has signed a cascade of early purchase agreements for
First AstraZeneca, then Sanofi-GSK, Johnson & Johnson, Pfizer-BioNTech and finally CureVac: since August, the European Commission has signed a cascade of early purchase agreements for